Download MendeleyCrystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis.
Wang, Y., Ren, X., Li, T., Su, D., Zhang, R.(2024) Biochem Biophys Res Commun 731: 150390-150390
- PubMed: 39024980
- DOI: https://doi.org/10.1016/j.bbrc.2024.150390
- Primary Citation of Related Structures:
9IJB - PubMed Abstract:
6-phosphogluconate dehydrogenase (6PGDH) is an essential enzyme in energy metabolism and redox reactions, and represents a potential drug target for the development of therapies targeting trypanosomes, plasmodium, or other pathogens. Tuberculosis, caused by Mycobacterium tuberculosis, is a contagious disease that severely affects human health, with approximately one-third of the world's population infected. However, the protein structure, exact oligomeric state, and catalytic mechanism of 6PGDH in Mycobacterium tuberculosis (Mt6PGDH) have remained largely unknown. In this study, we successfully purified and determined the structure of Mt6PGDH, revealing its function as a tetramer in both solution and crystal states. Through structural comparisons, we clarified the tetramer formation mechanism and the oligomeric organization of short-chain 6PGDHs. Additionally, we identified key residues for coenzyme recognition and catalytic activity. This work not only deepens our understanding of the enzymatic function of Mt6PGDH but also lays a foundation for the development of drugs targeting this enzyme.
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, PR China; State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
Organizational Affiliation:
